Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,74%
1 094,84
+18,71
+1,74%
—1 076,131 079,891 100,771 079,89——
SIXC
Communications
SIXC
Communications
SIXC
-0,42%
604,21
-2,53
-0,42%
—606,74606,74607,90602,03——
SIXE
Energy
SIXE
Energy
SIXE
+0,07%
1 249,71
+0,89
+0,07%
—1 248,821 246,371 256,421 239,08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,86%
1 739,26
+14,90
+0,86%
—1 724,361 733,021 745,751 727,76——
SIXM
Financials
SIXM
Financials
SIXM
+0,01%
635,63
+0,040
+0,01%
—635,59635,08637,96633,31——
SIXR
Staples
SIXR
Staples
SIXR
+0,61%
848,32
+5,17
+0,61%
—843,15842,50852,77840,85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,22%
216,76
+0,47
+0,22%
—216,29216,29217,30215,24——
SIXT
Technology
SIXT
Technology
SIXT
+2,20%
3 335,14
+71,73
+2,20%
—3 263,413 296,253 343,663 295,42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,01%
939,34
+0,10
+0,01%
—939,24941,57948,11939,11——
SIXV
Health care
SIXV
Health care
SIXV
+0,38%
1 468,17
+5,61
+0,38%
—1 462,561 465,031 471,561 459,66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,28%
2 387,09
+6,69
+0,28%
—2 380,402 394,922 412,132 386,82——
EKSO:NASDAQ
Ekso Bionics Holdings Inc
11,80 US$
+1,29%
(+0,15) 1D
12,00 US$
+1,69% (+0,20)
After hours
Closed: 4 მაი, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EKSO...
Mkt. cap
42,05 მლნ.
Avg. vol.
55,47 ათ.
Volume
0,00
52-wk high
13,50 US$
52-wk low
2,75 US$
EPS
-4,91 US$
Beta
0,86
Shares outstanding
3,56 მლნ.
No. of employees
50
News stories
From sources across the web
Profile
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
About Ekso Bionics Holdings Inc
CEOსკოტ დავის
Employees50
Founded2005
HeadquartersSan Rafael, კალიფორნია, ამერიკის შეერთებული შტატები
SectorMedical device
Websiteeksobionics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
2,06 მლნ.
4,23 მლნ.
3,14 მლნ.
2,14 მლნ.
Cost of goods sold
1,24 მლნ.
1,68 მლნ.
1,47 მლნ.
1,07 მლნ.
Cost of revenue
1,24 მლნ.
1,68 მლნ.
1,47 მლნ.
1,07 მლნ.
Research and development expenses
852,00 ათ.
550,00 ათ.
31,00 ათ.
583,00 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,94 მლნ.
3,40 მლნ.
5,40 მლნ.
6,11 მლნ.
Operating expense
4,79 მლნ.
3,95 მლნ.
5,43 მლნ.
6,69 მლნ.
Total operating expenses
6,03 მლნ.
5,63 მლნ.
6,90 მლნ.
7,76 მლნ.
Operating income
-3,98 მლნ.
-1,40 მლნ.
-3,76 მლნ.
-5,62 მლნ.
Other non operating income
-8,00 ათ.
-5,00 ათ.
20,00 ათ.
-740,00 ათ.
EBT including unusual items
-2,71 მლნ.
-1,42 მლნ.
-4,67 მლნ.
-6,88 მლნ.
EBT excluding unusual items
-2,71 მლნ.
-1,42 მლნ.
-3,92 მლნ.
-6,74 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,71 მლნ.
-1,42 მლნ.
-4,67 მლნ.
-6,88 მლნ.
Net profit margin
-131,70%
-33,62%
-148,85%
-321,58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-65,00 ათ.
-18,00 ათ.
-155,00 ათ.
-143,00 ათ.
Net interest expenses
-65,00 ათ.
-18,00 ათ.
-155,00 ათ.
-143,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,60 მლნ.
-1,04 მლნ.
-3,31 მლნ.
-5,16 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer